Clinical Trials
15 trialsNCT05073315 2024-02-09
A Comparative Study Between ABP 501 and Humira® in Participants With Moderate to Severe Plaque Psoriasis
Amgen
Phase 3 Completed
NCT04551352 2022-10-03
A Study of RO7293583 in Participants With Unresectable Metastatic Tyrosinase Related Protein 1 (TYRP1)-Positive Melanomas
Hoffmann-La Roche
Phase 1 Completed
NCT02762955 2021-09-08
CALYPSO
Biocad
Phase 3 Completed
NCT02092467 2021-08-17
Safety Study Of Tofacitinib Versus Tumor Necrosis Factor (TNF) Inhibitor In Subjects With Rheumatoid Arthritis
Pfizer
Phase 4 Completed
NCT02163759 2021-07-23
HIBISCUS I
Hoffmann-La Roche
Phase 3 Completed
NCT02171429 2021-07-23
HIBISCUS II
Hoffmann-La Roche
Phase 3 Completed
NCT02912247 2019-03-07
Comparative Clinical Trial to Evaluate Bioequivalency and Safety of Monoclonal Antibody Injection and Adalimumab in Chinese Healthy Volunteers
Innovent Biologics (Suzhou) Co. Ltd.
Phase 1 Completed
NCT02499783 2019-01-04
Study to Evaluate the Safety and Efficacy of Adalimumab in Chinese Subjects With Moderate to Severe Crohn's Disease
AbbVie
Phase 3 Completed
NCT02893254 2018-06-04
Efficacy and Safety of IBI303 in Adult Patients With Active Ankylosing Spondylitis
Innovent Biologics (Suzhou) Co. Ltd.
Phase 3 Completed
NCT02196701 2018-03-19
CLEAR
AbbVie
Phase 3 Completed
NCT01635764 2018-01-24
PIONEER (OLE)
AbbVie
Phase 3 Completed
NCT00595413 2016-02-17
AUGUST II
EMD Serono
Phase 2 Completed
NCT00420927 2012-04-18
OPTIMA
Abbott
Phase 4 Completed
NCT01078571 2011-10-28
DALI
Abbott
Completed
NCT00085644 2011-04-21
ATLAS
Abbott
Phase 3 Completed